ebook Munafa Stock Market Course + Intraday & FNO calls  

       

524816 announcements Natco Pharm announcements and dividends declared BSE

Natco Pharm Complete list of announcements declared & dividend announcements by Natco Pharm 524816

Natco Pharm 524816 listed on BSE and deals in

Announcements and dividends declared by Natco Pharm 524816

Natco Pharma shares crash 15% after weak Q4 results; net profit tanks 34% YoY
Natco Pharma shares plunged after the company reported a steep fall in fourth-quarter profit, revenue and EBITDA. Weak operating margins and lower annual earnings weighed on investor sentiment despite a one-time tax-related benefit recorded during the quar
Announcement as on 29 May 2026

Natco Pharma, Eris Lifesciences shares jump up to 6% on partnership for Semaglutide launch in India
Shares of Natco Pharma and Eris Lifesciences climbed on Tuesday after announcing a partnership to commercialise Semaglutide in India. Natco rose over 6% to its highest level since January 8, while Eris gained nearly 4%, marking its third straight session o
Announcement as on 24 February 2026

Volumes jump at Natco Pharma Ltd counter
Natco Pharma Ltd witnessed volume of 188.67 lakh shares by 14:14 IST on NSE, a 30.19 times surge over two-week average daily volume of 6.25 lakh shares
Announcement as on 16 February 2026

Natco Pharma shares drop over 5% after previous day’s double-digit gains
Natco Pharma shares fell as investors booked profits after a sharp rally in the previous session. The stock has been volatile this week, slipping earlier after the US FDA issued seven Form-483 observations at its Manali API plant, which the company said we
Announcement as on 27 November 2025

Natco Pharma shares jump over 5% after three-day slump
Natco Pharma shares surged on Wednesday, bouncing back from a three-day decline that followed a US FDA inspection of its API manufacturing facility in Manali, Chennai, conducted from November 17–21, 2025. The inspection flagged seven Form-483 observations,
Announcement as on 26 November 2025

Announcements by Natco Pharm first page | Next page |

524816 Natco Pharm current price & indicator signals

Moving Averages for Natco Pharm

  • 5Day Average: 875
  • 12Day Average: 867.65
  • 20Day Average: 934.55
  • 50Day Average: 1050.73
  • 100Day Average: 988.14
  • 150Day Average: 954.11
  • 200Day Average: 924.48

524816 Indicators & signals

Indicator MACD (12,26,9)

894, 952.46, -61.12
Indicator MACD is in negative zone

Indicator ADX (14)

23.26, 18.64, 29.93
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 42
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 524816 Natco Pharm are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
22 Mon Jun 2026 884.35 881.80 to 892.75 -0.5% 0.19 times
19 Fri Jun 2026 888.75 877.00 to 909.00 0.62% 0.53 times
18 Thu Jun 2026 883.25 862.80 to 895.80 1.86% 1.44 times
17 Wed Jun 2026 867.10 844.05 to 869.00 1.83% 0.87 times
16 Tue Jun 2026 851.55 841.50 to 858.25 0.47% 0.29 times
15 Mon Jun 2026 847.55 839.80 to 888.95 -1.89% 1.03 times
12 Fri Jun 2026 863.85 849.75 to 866.00 2.53% 0.7 times
11 Thu Jun 2026 842.55 839.35 to 874.90 -1.46% 1.13 times
10 Wed Jun 2026 855.00 852.00 to 876.35 -1.22% 0.72 times
09 Tue Jun 2026 865.55 856.10 to 879.70 -0.35% 1.03 times
08 Mon Jun 2026 868.60 864.95 to 908.65 -2.8% 2.26 times
05 Fri Jun 2026 893.65 890.15 to 927.00 -2.75% 1.87 times

Videos related to: 524816 announcements Natco Pharm announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

524816 announcements Natco Pharm announcements and dividends declared BSE

 

Back to top